+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cefdinir"

Cephalosporin Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cephalosporin Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 195 Pages
  • Global
From
Cephalosporin Drugs Market Report 2025 - Product Thumbnail Image

Cephalosporin Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Cephalosporin Markets in China - Product Thumbnail Image

Cephalosporin Markets in China

  • Report
  • October 2024
  • 270 Pages
  • China
From
Cephalosporin Industry Forecasts - China Focus - Product Thumbnail Image

Cephalosporin Industry Forecasts - China Focus

  • Report
  • October 2024
  • 135 Pages
  • China
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Cefdinir is an antibiotic used to treat a variety of bacterial infections. It belongs to the cephalosporin class of antibiotics, which are used to treat a wide range of bacterial infections. Cefdinir is used to treat infections caused by bacteria, such as bronchitis, pneumonia, ear infections, skin infections, and urinary tract infections. It is also used to treat certain sexually transmitted diseases. Cefdinir is available in both oral and intravenous forms. Cefdinir is a widely used antibiotic in the treatment of bacterial infections. It is generally well tolerated and has a low risk of side effects. It is also relatively inexpensive compared to other antibiotics. Cefdinir is often prescribed as a first-line treatment for bacterial infections, as it is effective against a wide range of bacteria. The cefdinir market is highly competitive, with many companies offering cefdinir products. Some of the major companies in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more